Biotherapeutic antibody discovery is inherently challenging. Amongst the clinically proven technologies for antibody discovery is phage display — a technique utilized by one of the most recent and innovative solutions on the market: the Pioneer Antibody Discovery Platform.

The Pioneer Platform features what we believe to be the largest fully human, synthetic phage display library currently in existence, and its proprietary SpyDisplay technology enables fast delivery of biotherapeutic leads. Our scientists have bioengineered the platform to minimize sequence liabilities and maximize the functional library space, with 90% of sequences encoding functional light and heavy chains. Antibodies derived from the Pioneer Platform show high homology to germline sequences, resulting in leads with high developability, diversity, and affinity. Discover the service and how its technology can help you identify your next biotherapeutic leads faster and fast-forward your discovery pipeline.

Previous post

Efficacy of a Novel Treatment for Multiple Myeloma Established by Flow Cytometry

Next post

Did You Know That Beyond Sensitivity, ddPCR Provides Unrivaled Precision and Accuracy?